Today: 17 May 2026
Figure Technology Solutions stock (FIGR) steadies before the bell after 18% jump, lock-up looms
3 March 2026
1 min read

Figure Technology Solutions stock (FIGR) steadies before the bell after 18% jump, lock-up looms

New York, March 3, 2026, 09:15 (EST) — Premarket

  • FIGR traded at $29.72 before the bell, following a 17.6% surge on Monday.
  • Goldman Sachs lowered its 12-month price target to $44, down from $49, but is sticking with its Buy rating.
  • The post-IPO lock-up blocking insider sales is due to expire March 10

Figure Technology Solutions Inc (FIGR.O) hovered near flat in Tuesday’s premarket, last quoted at $29.72. The stock had surged 17.6% during the prior session.

The stock’s sudden jump is drawing traders’ attention again, landing it in the spotlight before a busy week packed with possible triggers. One key event: the post-IPO lock-up expires next Tuesday, which might boost the share supply.

Crypto sentiment factors in here. Bitcoin popped roughly 2.5%, trading near $67,100 during early U.S. hours.

Goldman Sachs cut its 12-month price target on Figure to $44 from $49 on Monday but stuck with a “Buy” rating, Investing.com’s analyst summary shows. That price target signals where analysts expect the stock might be a year from now. Investing.com

Late last week, the company rolled out its fourth-quarter numbers and unveiled a $200 million buyback. Chief executive Michael Tannenbaum, in the official release, emphasized the drive to “expand our partner network” as the group deepens its move into blockchain-based capital markets. GlobeNewswire

During the Feb. 26 earnings call, CFO Macrina Kgil pointed to seasonal trends, telling analysts, “We do anticipate higher growth in March,” following what she called slower winter months. MarketBeat

Figure calls itself a blockchain-native capital marketplace, connecting loan origination, funding, and secondary market activity. Its product lineup ranges from consumer credit to digital assets.

The New York-based company debuted on the public markets in September 2025, setting its IPO price at $25 per share. Shares kicked off trading at $36, closing the session with a roughly 44% gain and landing the firm’s market cap near $7.62 billion, according to Reuters.

The IPO triggered a standard lock-up, barring insiders and early investors from offloading shares right away. According to MarketBeat’s lock-up calendar, Figure insiders will see their restriction lift on March 10.

But lock-up expiries don’t always play out the same way. If sellers hit the market early, shares can come under pressure—even when sentiment is turning up. FIGR has already swung sharply both ways.

Stock Market Today

  • Lee Shares PGA Championship Lead After First Round at Aronimink
    May 16, 2026, 11:37 PM EDT. Kim Lee surged to a share of the lead at the PGA Championship after carding a three-under-par 67 at Aronimink Golf Club. The 27-year-old Australian made five birdies in a strong, aggressive start, marking his first lead in 19 major appearances. Fellow Australians Jason Day and Cameron Smith also posted solid rounds of one-under 69 to remain in contention. Lee credited a revamped mindset for his performance, overcoming a prior missed cut at the Masters. The challenging course saw Lee carefully manage the rough and aggressive pin targets. Day, a 2015 champion, and Smith, the 2022 Open winner, are poised for potential major success, while Adam Scott and Elvis Smylie trail by five strokes. Travis Smyth struggled with a 74, risking his cut chances.

Latest articles

Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
MARA stock jumps premarket as annual filing opens door to selling bitcoin stash
Previous Story

MARA stock jumps premarket as annual filing opens door to selling bitcoin stash

Silver plunges as Iran war boosts dollar and delays Fed cuts — SLV back in focus
Next Story

Silver plunges as Iran war boosts dollar and delays Fed cuts — SLV back in focus

Go toTop